Related Experiment Video
Updated: Aug 13, 2026
12:49
Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation
Published on: March 21, 2020
The serum ferrokinetics in Parkinson's disease
Gaoxiong Yi Xue Ke Xue Za Zhi = the Kaohsiung Journal of Medical Sciences
|November 1, 1992
Summary
Parkinson's disease (PD) patients showed normal systemic iron levels, suggesting low dopamine isn't caused by low body iron. Central iron regulation may differ in PD patients.
Area of Science:
- Neuroscience
- Biochemistry
- Medical Research
Background:
- Ferrous ion is crucial for dopamine synthesis.
- Decreased iron may reduce dopamine production in the nigrostriatal system, a key mechanism in Parkinson's disease (PD).
- This suggests potential abnormalities in systemic ferrokinetics for PD patients.
Purpose of the Study:
- To investigate systemic ferrokinetics in Parkinson's disease patients.
- To determine if reduced systemic iron levels contribute to decreased dopamine production in PD.
Main Methods:
- Analyzed serum iron, ferritin, total-iron-binding-capacity (TIBC), and transferrin saturation.
- Compared levels in 15 PD patients against 30 healthy controls.
Main Results:
- Serum iron was slightly lower in PD patients but not statistically significant.
- Ferritin, TIBC, and transferrin saturation levels were similar between PD patients and controls.
- Systemic ferrokinetics appeared normal in the studied PD cohort.
Conclusions:
- The reduction of central dopamine in Parkinson's disease is unlikely to be caused by hypoferruginemia (low systemic iron).
- Evidence suggests a potential difference in ferrokinetics between central and systemic compartments in PD.
Related Concept Videos
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...